Apr 15, 2026 9:00am EDT Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
Mar 18, 2026 8:30am EDT Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
